Favinil 200
- Favinil: A potent influenza antiviral approved for production in Japan.
- Targets the RNA polymerase crucial for viral replication within human cells.
- Reserved for novel or re-emerging influenza outbreaks where conventional antivirals fall short.
- Promising implications for COVID-19 treatment.
- Distribution overseen by Japan’s Health Ministry.
- Efficacy against various influenza strains underscores its significance in combating viral infections.